BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 30717762)

  • 21. Management of high grade dysplasia in Barrett's oesophagus with underlying oesophageal varices: A retrospective study.
    Palmer WC; Di Leo M; Jovani M; Heckman MG; Diehl NN; Iyer PG; Wolfsen HC; Wallace MB
    Dig Liver Dis; 2015 Sep; 47(9):763-8. PubMed ID: 26066379
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adenocarcinoma arising in Barrett's oesophagus: evidence for the participation of p53 dysfunction in the dysplasia/carcinoma sequence.
    Hardwick RH; Shepherd NA; Moorghen M; Newcomb PV; Alderson D
    Gut; 1994 Jun; 35(6):764-8. PubMed ID: 8020801
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel Aberrations Uncovered in Barrett's Esophagus and Esophageal Adenocarcinoma Using Whole Transcriptome Sequencing.
    Maag JLV; Fisher OM; Levert-Mignon A; Kaczorowski DC; Thomas ML; Hussey DJ; Watson DI; Wettstein A; Bobryshev YV; Edwards M; Dinger ME; Lord RV
    Mol Cancer Res; 2017 Nov; 15(11):1558-1569. PubMed ID: 28751461
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Global DNA methylation patterns in Barrett's esophagus, dysplastic Barrett's, and esophageal adenocarcinoma are associated with BMI, gender, and tobacco use.
    Kaz AM; Wong CJ; Varadan V; Willis JE; Chak A; Grady WM
    Clin Epigenetics; 2016; 8():111. PubMed ID: 27795744
    [TBL] [Abstract][Full Text] [Related]  

  • 25. IGFBP-3 and IGFBP-10 (CYR61) up-regulation during the development of Barrett's oesophagus and associated oesophageal adenocarcinoma: potential biomarkers of disease risk.
    Di Martino E; Wild CP; Rotimi O; Darnton JS; Olliver RJ; Hardie LJ
    Biomarkers; 2006; 11(6):547-61. PubMed ID: 17056474
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular Evolution of Metaplasia to Adenocarcinoma in the Esophagus.
    Grady WM; Yu M
    Dig Dis Sci; 2018 Aug; 63(8):2059-2069. PubMed ID: 29766388
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reflux control is important in the management of Barrett's Esophagus: results from a retrospective 1,830 patient cohort.
    Brown CS; Lapin B; Wang C; Goldstein JL; Linn JG; Denham W; Haggerty SP; Talamonti MS; Howington JA; Carbray J; Ujiki MB
    Surg Endosc; 2015 Dec; 29(12):3528-34. PubMed ID: 25676204
    [TBL] [Abstract][Full Text] [Related]  

  • 28. K-ras point mutations are rare events in premalignant forms of Barrett's oesophagus.
    Trautmann B; Wittekind C; Strobel D; Meixner H; Keymling J; Gossner L; Ell C; Hahn EG
    Eur J Gastroenterol Hepatol; 1996 Aug; 8(8):799-804. PubMed ID: 8864678
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adenocarcinoma and Barrett's oesophagus. A clinico-pathological study.
    Moghissi K; Sharpe DA; Pender D
    Eur J Cardiothorac Surg; 1993; 7(3):126-31. PubMed ID: 8461144
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Paired exome analysis of Barrett's esophagus and adenocarcinoma.
    Stachler MD; Taylor-Weiner A; Peng S; McKenna A; Agoston AT; Odze RD; Davison JM; Nason KS; Loda M; Leshchiner I; Stewart C; Stojanov P; Seepo S; Lawrence MS; Ferrer-Torres D; Lin J; Chang AC; Gabriel SB; Lander ES; Beer DG; Getz G; Carter SL; Bass AJ
    Nat Genet; 2015 Sep; 47(9):1047-55. PubMed ID: 26192918
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evolution and progression of Barrett's oesophagus to oesophageal cancer.
    Killcoyne S; Fitzgerald RC
    Nat Rev Cancer; 2021 Nov; 21(11):731-741. PubMed ID: 34545238
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genome-wide catalogue of chromosomal aberrations in barrett's esophagus and esophageal adenocarcinoma: a high-density single nucleotide polymorphism array analysis.
    Gu J; Ajani JA; Hawk ET; Ye Y; Lee JH; Bhutani MS; Hofstetter WL; Swisher SG; Wang KK; Wu X
    Cancer Prev Res (Phila); 2010 Sep; 3(9):1176-86. PubMed ID: 20651033
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clonal analysis of a case of multifocal oesophageal (Barrett's) adenocarcinoma by comparative genomic hybridization.
    van Dekken H; Vissers CJ; Tilanus HW; Tanke HJ; Rosenberg C
    J Pathol; 1999 Jul; 188(3):263-6. PubMed ID: 10419593
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immune determinants of Barrett's progression to esophageal adenocarcinoma.
    Lagisetty KH; McEwen DP; Nancarrow DJ; Schiebel JG; Ferrer-Torres D; Ray D; Frankel TL; Lin J; Chang AC; Kresty LA; Beer DG
    JCI Insight; 2021 Jan; 6(1):. PubMed ID: 33290281
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression profiles of cancer stem cell markers: CD133, CD44, Musashi-1 and EpCAM in the cardiac mucosa-Barrett's esophagus-early esophageal adenocarcinoma-advanced esophageal adenocarcinoma sequence.
    Mokrowiecka A; Veits L; Falkeis C; Musial J; Kordek R; Lochowski M; Kozak J; Wierzchniewska-Lawska A; Vieth M; Malecka-Panas E
    Pathol Res Pract; 2017 Mar; 213(3):205-209. PubMed ID: 28216140
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Somatic DNA copy number alterations in non-dysplastic Barrett's esophagus.
    Callahan ZM; Liu W; Hou J; Zheng SL; Rehman J; Hedberg HM; Brown CS; Su B; Attaar M; Kuchta K; Regner M; Carbray J; Xu J; Ujiki M
    Surg Endosc; 2021 Jul; 35(7):3961-3970. PubMed ID: 32749611
    [TBL] [Abstract][Full Text] [Related]  

  • 37. K-ras codon 12 mutations in Barrett's oesophagus and adenocarcinomas of the oesophagus and oesophagogastric junction.
    Lord RV; O'Grady R; Sheehan C; Field AF; Ward RL
    J Gastroenterol Hepatol; 2000 Jul; 15(7):730-6. PubMed ID: 10937677
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biomarker identification and trans-regulatory network analyses in esophageal adenocarcinoma and Barrett's esophagus.
    Lv J; Guo L; Wang JH; Yan YZ; Zhang J; Wang YY; Yu Y; Huang YF; Zhao HP
    World J Gastroenterol; 2019 Jan; 25(2):233-244. PubMed ID: 30670912
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeted genetic and epigenetic profiling of esophageal adenocarcinomas and non-dysplastic Barrett's esophagus.
    Pinto R; Hauge T; Jeanmougin M; Pharo HD; Kresse SH; Honne H; Winge SB; Five MB; Kumar T; Mala T; Hauge T; Johnson E; Lind GE
    Clin Epigenetics; 2022 Jun; 14(1):77. PubMed ID: 35701814
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of the premalignant stages of Barrett's oesophagus through to adenocarcinoma by comparative genomic hybridization.
    Croft J; Parry EM; Jenkins GJ; Doak SH; Baxter JN; Griffiths AP; Brown TH; Parry JM
    Eur J Gastroenterol Hepatol; 2002 Nov; 14(11):1179-86. PubMed ID: 12439111
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.